Veneno Technologies will present at the 15th Annual Texas Life Science Forum on November 10, 2026, in Houston, Texas.
Co-hosted by the Rice Alliance and BioHouston, the forum brings together life science startups, investors, and leaders from industry and academia. CEO Takatoshi Kuno will introduce Veneno’s drug discovery platform, which combines venom-derived disulfide-rich peptides (DRPs) with AI, and share the company’s plans to develop targeted radiopharmaceuticals for cancer.
Related link:
Texas Life Science Forum Official Website
Participating Companies (including Veneno Technologies)
